92 related articles for article (PubMed ID: 2456111)
1. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
Stoessl AJ; Dourish CT; Iversen SD
Br J Pharmacol; 1988 Jun; 94(2):285-7. PubMed ID: 2456111
[TBL] [Abstract][Full Text] [Related]
2. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.
Stoessl AJ; Dourish CT; Young SC; Williams BJ; Iversen SD; Iversen LL
Neurosci Lett; 1987 Oct; 80(3):321-6. PubMed ID: 2446214
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT.
Stoessl AJ; Dourish CT; Iversen SD
Brain Res; 1990 May; 517(1-2):111-6. PubMed ID: 1695859
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
5. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Nordquist RE; Durkin S; Jacquet A; Spooren W
Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
[TBL] [Abstract][Full Text] [Related]
6. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats.
Itoi K; Tschöpe C; Jost N; Culman J; Lebrun C; Stauss B; Unger T
Eur J Pharmacol; 1992 Sep; 219(3):435-44. PubMed ID: 1385176
[TBL] [Abstract][Full Text] [Related]
7. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
Stoessl AJ; Dourish CT; Iversen SD
Psychopharmacology (Berl); 1988; 95(4):502-6. PubMed ID: 2463651
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide.
Improta G; Broccardo M
Peptides; 1991; 12(6):1433-4. PubMed ID: 1726124
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of senktide-induced tail whips.
Nordquist RE; Ballard TM; Algeyer B; Pauly-Evers M; Ozmen L; Spooren W
Neuropharmacology; 2010 Jan; 58(1):259-67. PubMed ID: 19540857
[TBL] [Abstract][Full Text] [Related]
10. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
Yip J; Chahl LA
Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
[TBL] [Abstract][Full Text] [Related]
11. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions.
Stoessl AJ; Szczutkowski E; Glenn B; Watson I
Brain Res; 1991 Nov; 565(2):254-62. PubMed ID: 1668812
[TBL] [Abstract][Full Text] [Related]
12. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats.
Liminga U; Johansson PE; Gunne L
Pharmacol Biochem Behav; 1991 Mar; 38(3):617-20. PubMed ID: 1712496
[TBL] [Abstract][Full Text] [Related]
13. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.
Stoessl AJ; Hill DR
Brain Res; 1990 Nov; 534(1-2):1-7. PubMed ID: 1705846
[TBL] [Abstract][Full Text] [Related]
15. The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat.
Massi M; Polidori C; Gentili L; Perfumi M; de Caro G; Maggi CA
Neurosci Lett; 1988 Oct; 92(3):341-6. PubMed ID: 2462199
[TBL] [Abstract][Full Text] [Related]
16. Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats.
Ciccocioppo R; Panocka I; Stefanini E; Gessa GL; Massi M
Pharmacol Biochem Behav; 1995 May; 51(1):21-7. PubMed ID: 7542392
[TBL] [Abstract][Full Text] [Related]
17. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
18. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
[TBL] [Abstract][Full Text] [Related]
19. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
Keegan KD; Woodruff GN; Pinnock RD
Br J Pharmacol; 1992 Jan; 105(1):3-5. PubMed ID: 1375857
[TBL] [Abstract][Full Text] [Related]
20. Central administration of senktide, a tachykinin NK-3 agonist, has an antidiuretic action by stimulating AVP release in water-loaded rats.
Saigo A; Takano Y; Matsumoto T; Tran M; Nakayama Y; Saito R; Yamada K; Kamiya H
Neurosci Lett; 1993 Sep; 159(1-2):187-90. PubMed ID: 7505413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
